Clinical trial
EndoClotTM Absorbable Polysaccharide Hemostat in Comparison With Metallic Hemoclip for Hemostasis and Preventing Post-procedure Bleeding After Endoscopic Mucosal Resection: a Prospective, Randomized Trial
NCT01496781 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EndoClotTM Absorbable Polysaccharide Hemostat in Comparison With Metallic Hemoclip for Hemostasis and Preventing Post-procedure Bleeding After Endoscopic Mucosal Resection: a Prospective, Randomized Trial
- Lead sponsor
- Xijing Hospital of Digestive Diseases
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- March 31, 2012
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colonic polyps, endoscopic hemostasis